OTC · Financial Statements
Canntab Therapeutics Limited (CTABF) Financial Statements
$0.00
OTC: CTABF
Market Cap $3891
Overview Financials Dividend Canntab Therapeutics Limited most recently reported annual revenue of $0, net profit of $-4.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $0 $0 $0 $0 $0 Operating Profit $-2.0M $-3.0M $-3.0M $-4.0M $-4.0M Net Profit $-2.0M $-2.0M $-3.0M $-4.0M $-4.0M EPS $-0.11 $-0.10 $-0.10 $-0.13 $-0.10 Op Margin -9087.7% -1042.4% -1961.8% — -1419.4%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $5.0M $3.0M $6.0M $6.0M $3.0M Total Liabilities $0 $0 $2.0M $4.0M $3.0M Cash $4.0M $0 $2.0M $1.0M $1.0M Borrowings $0 $0 $1.0M $2.0M $2.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-1.0M $-2.0M $-2.0M $-3.0M $-3.0M Investing Cash Flow $0 $2.0M $-1.0M $-1.0M $0 Financing Cash Flow $0 $0 $0 $0 $1.0M Net Cash Flow $3.0M $0 $2.0M $-1.0M $-1.0M Free Cash Flow $-1.0M $-3.0M $-3.0M $-3.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.46 FCF Yield -53685.53% Quick Ratio 0.38 Interest Coverage -7.35 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock